ReviewHuman reproduction open2023

Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?

Paolo Vercellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.